WinWay Health Blog

Boehringer Ingelheim intends to make a significant investment in its three manufacturing sites in Mexico in the next three years, starting with its site...

A company set up to take biomedical research from academia and build companies around it has revealed its first portfolio company. ElevateBio, a Cambridge, Massachusetts-based...

Novartis has said its forthcoming spinal muscular atrophy gene therapy could be cost-effective at a price of up to $5 million, but now the...

Last year, Japanese drugmaker Otsuka Pharmaceutical paid $430 million to acquire Waltham, Massachusetts-based Visterra, a firm that combines computational and experimental technologies to develop...

When it comes to Invokana sales, Johnson & Johnson needs a way to stop the bleeding. And it just got one step closer to...